ASCF(600855) 证券时报网·2024-12-25 02:20Group 1 - The brain-computer interface (BCI) sector is gaining significant attention in China, with various companies experiencing stock price increases, indicating a growing market interest [1] - The Chinese government is prioritizing the development of BCI technology, viewing it as a representative of future industries and new productive forces [1][2] - Clinical trials for BCI products are advancing, with companies like Borui Kang and Qingshua University completing significant trials, and BrainCo receiving FDA certification for its non-invasive BCI products [1] Group 2 - The Shanghai Municipal Government has issued a work plan to enhance medical artificial intelligence, focusing on BCI and related fields, encouraging collaboration among laboratories, research institutions, and medical facilities [2] - CITIC Securities highlights BCI as a promising direction for new productive forces, with domestic and international companies pushing for commercialization across various sectors [3] - There is a strong emphasis on breaking foreign technology monopolies and developing independent solutions within the BCI industry, with a focus on consumer-grade products and applications benefiting from BCI technology [3]